Perioperative safety and effectiveness of neoadjuvant therapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel plus apatinib in locally advanced gastric cancer

Y Zhang, B Zhang, J Yang, J Zhang… - Cancer management …, 2021 - Taylor & Francis
Purpose The trend in neoadjuvant therapy for locally advanced gastric cancer (LAGC) is to
use more drugs or therapies in combination. This study aimed to assess the safety and …
被引用次数：8 相关文章
[PDF] semanticscholar.org

[PDF][PDF] Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced …

Y Zhang, B Zhang, J Yang… - Cancer Management …, 2021 - pdfs.semanticscholar.org
Purpose: The trend in neoadjuvant therapy for locally advanced gastric cancer (LAGC) is to
use more drugs or therapies in combination. This study aimed to assess the safety and …

Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric …

Y Zhang, B Zhang, J Yang, J Zhang… - Cancer Management …, 2021 - europepmc.org
Purpose The trend in neoadjuvant therapy for locally advanced gastric cancer (LAGC) is to
use more drugs or therapies in combination. This study aimed to assess the safety and …

Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric …

Y Zhang, B Zhang, J Yang, J Zhang… - Cancer Management and …, 2021 - go.gale.com
Purpose: The trend in neoadjuvant therapy for locally advanced gastric cancer (LAGC) is to
use more drugs or therapies in combination. This study aimed to assess the safety and …

Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric …

Y Zhang, B Zhang, J Yang… - Cancer management …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose The trend in neoadjuvant therapy for locally advanced gastric cancer (LAGC) is to
use more drugs or therapies in combination. This study aimed to assess the safety and …
[HTML] nih.gov

[HTML][HTML] Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced …

Y Zhang, B Zhang, J Yang, J Zhang… - Cancer Management …, 2021 - ncbi.nlm.nih.gov
Purpose The trend in neoadjuvant therapy for locally advanced gastric cancer (LAGC) is to
use more drugs or therapies in combination. This study aimed to assess the safety and …

Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric …

Y Zhang, B Zhang, J Yang, J Zhang… - Cancer Management …, 2021 - search.proquest.com
Purpose: The trend in neoadjuvant therapy for locally advanced gastric cancer (LAGC) is to
use more drugs or therapies in combination. This study aimed to assess the safety and …

Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric …

Y Zhang, B Zhang, J Yang, J Zhang… - Cancer Management …, 2021 - dovepress.com
Purpose: The trend in neoadjuvant therapy for locally advanced gastric cancer (LAGC) is to
use more drugs or therapies in combination. This study aimed to assess the safety and …